Category
August 20, 2020
PI: Leonidas Bleris, PhD Co-PI: Alexander Pertsemlidis, PhD (UT Dallas) (UT Health San Antonio) PROJECT SUMMARY Collaborative Research: Unraveling extracellular microRNA communication Overview: […]
August 20, 2020
Although cancer is the leading cause of disease-related mortality in children, the relative rarity of pediatric cancers poses a significant challenge for developing novel therapeutics to further improve prognosis. Patient-derived xenograft (PDX) models, which are usually developed from high-risk tumors, are a useful platform to study molecular driver events, identify biomarkers and prioritize therapeutic agents.
August 20, 2020
PROJECT SUMMARY Glioblastoma (GBM) is the most common and most aggressive brain tumor type among adults with a 14 months average patient survival. Despite all genomic efforts in recent years, novel therapies based on GBM common mutations and alterations have been disappointing. To build an alternative route, we have been focusing on oncogenic RNA binding [...]August 11, 2020
Congratulations to one of our CSA graduate students Pooja Yadav, M.S. (Cancer Biology discipline) who successfully defended her PhD dissertation on June 25!
August 5, 2020
Like a thief in the night, Covid-19 can disguise itself to easily enter and infect cells in the human body. A new research study details what cells are more susceptible to the coronavirus. SARS-CoV-2 can mimic the proteins of a human cell to evade detection by the immune system. Once inside the cell, it can […]
July 30, 2020
July 30, 2020
Researchers announced Friday that they have discovered an enzyme that helps COVID-19 enter cells in the human body, allowing the infection to grow. Called non-structural protein 16, or nsp16, the enzyme is produced by the new coronavirus and acts as a “camouflage,” tricking human cells into thinking that the virus is “part of its own code and […]
July 28, 2020
SARS-CoV-2, the coronavirus that causes COVID-19, has been labeled with a variety of different adjectives over the past few months. Deadly, awful, and evil, just to name a few. Now, according to a new study from the University of Texas Health Science Center San Antonio, another descriptor can be added to the coronavirus’ modus operandi: deceitful.
July 28, 2020
SOURCE: WOAI Broadcast Date: July 27, 2020 A new discovery by researchers right here in San Antonio is giving doctors a better idea about how the coronavirus works. “I’m still not 100 percent,” said Rudy Palacios, a man who battled COVID-19 in a hospital for 16 days. “I actually was released from the hospital on […]
July 28, 2020
With an alarm code, we can enter a building without bells going off. It turns out that the SARS coronavirus 2 (SARS-CoV-2) has the same advantage entering cells. It possesses the code to waltz right in. On July 24 in Nature Communications, researchers at The University of Texas Health Science Center at San Antonio (UT Health San […]